Graham Capital Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-16,764
Closed -$549K – 1170
2025
Q4
$549K Buy
16,764
+6,420
+62% +$158K 0.01% 594
2025
Q3
$185K Sell
10,344
-15,681
-60% -$228K ﹤0.01% 1075
2025
Q2
$282K Buy
26,025
+3,576
+16% +$46.9K ﹤0.01% 1018
2025
Q1
$415K Buy
22,449
+9,582
+74% +$173K 0.01% 877
2024
Q4
$212K Buy
+12,867
New +$182K ﹤0.01% 1061
2024
Q3
– Sell
-15,583
Closed -$113K – 1101
2024
Q2
$113K Buy
+15,583
New +$107K ﹤0.01% 933
2022
Q4
– Sell
-10,955
Closed -$130K – 1050
2022
Q3
$130K Buy
+10,955
New +$110K 0.01% 1014

Other funds holding AXGN

Graham Capital Management's AXGN Position: Q1 2026 in Review

Graham Capital Management sold out of Axogen (AXGN) in Q1 2026, closing a stake of 16,764 shares — an estimated $549K sold.

Graham Capital Management first reported a position in AXGN in Q3 2022 and held it in 7 quarters. The position peaked at $549K in Q4 2025. 222 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Graham Capital Management reported no remaining Axogen position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 16,764 Axogen shares in Q1 2026, an estimated $549K.
  • Graham Capital Management first reported a position in Axogen in Q3 2022 and held it in 7 quarters.
  • Graham Capital Management's Axogen position peaked at $549K in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.